Literature DB >> 24064436

Antibiotic-associated diarrhea: a refresher on causes and possible prevention with probiotics--continuing education article.

Christy A Varughese1, Niyati H Vakil, Kristy M Phillips.   

Abstract

Antibiotic-associated diarrhea (AAD) describes any unexplained diarrhea associated with the use of an antibiotic. AAD also includes infection caused by Clostridium difficile, however this organism only accounts for a small percentage of diarrhea caused by antibiotics. AAD can be caused by multiple other organisms including C perfringens, S aureus, and Candida. Some antibiotics are more likely to cause non-C difficile AAD, such as erythromycin and the penicillin class. AAD develops through the loss of normal flora and reduced colonic bacterial carbohydrate metabolism during antibiotic administration. There is an increasing interest in the use of probiotics for the prevention of AAD. There are several meta-analyses that report a relative risk reduction of AAD with the use of probiotics during antibiotic administration. Interpretation of these studies has been challenging due to the heterogeneity and size of the patient populations, unclear probiotic regimen, and unclear safety profile. Since AAD can be a reason for a patient to become non-compliant or receive incomplete treatment, clinicians should monitor for this potential adverse effect caused by antibiotics.

Entities:  

Keywords:  Clostridium difficile; adverse drug reaction; antibiotic-associated diarrhea; prevention; probiotics

Mesh:

Substances:

Year:  2013        PMID: 24064436     DOI: 10.1177/0897190013499523

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  10 in total

Review 1.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

2.  Daptomycin-Associated Diarrhea: A Case Report and Review of the Literature.

Authors:  Abdalaziz M Awadelkarim; Isra Idris; Muhammad Abdelhai; Ahmed Yeddi; Eltaib Saad; Rashid Alhusain; John Dayco; Mohammed Ali; Lubna Salih
Journal:  Cureus       Date:  2022-06-20

3.  Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.

Authors:  F F Zhou; S Wu; J D Klena; H H Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-13       Impact factor: 3.267

Review 4.  Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages.

Authors:  Stephen T Abedon
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-09

5.  Temporal Development of Gut Microbiota in Triclocarban Exposed Pregnant and Neonatal Rats.

Authors:  Rebekah C Kennedy; Russell R Fling; Michael S Robeson; Arnold M Saxton; Robert L Donnell; John L Darcy; David A Bemis; Jiang Liu; Ling Zhao; Jiangang Chen
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

Review 6.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

7.  Surveys of parents and clinicians concerning the minimally important difference of probiotic therapy for prevention of paediatric antibiotic-associated diarrhoea.

Authors:  Samaneh Khanpour Ardestani; Joan L Robinson; Levinus A Dieleman; Hien Q Huynh; Hsing Jou; Sunita Vohra
Journal:  BMJ Open       Date:  2019-04-02       Impact factor: 2.692

8.  Changing mindsets about side effects.

Authors:  Kari A Leibowitz; Lauren C Howe; Alia J Crum
Journal:  BMJ Open       Date:  2021-02-01       Impact factor: 2.692

9.  Short and long-term effects of a synbiotic on clinical signs, the fecal microbiome, and metabolomic profiles in healthy research cats receiving clindamycin: a randomized, controlled trial.

Authors:  Jacqueline C Whittemore; Jennifer E Stokes; Nicole L Laia; Joshua M Price; Jan S Suchodolski
Journal:  PeerJ       Date:  2018-07-17       Impact factor: 2.984

10.  Effects of a synbiotic on the fecal microbiome and metabolomic profiles of healthy research cats administered clindamycin: a randomized, controlled trial.

Authors:  Jacqueline C Whittemore; Jennifer E Stokes; Joshua M Price; Jan S Suchodolski
Journal:  Gut Microbes       Date:  2019-02-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.